Provided by Tiger Trade Technology Pte. Ltd.

Advanced

279.56
+5.822.12%
Volume:19.91K
Turnover:5.57M
Market Cap:11.19B
PE:51.86
High:282.00
Open:280.28
Low:279.00
Close:273.74
52wk High:397.44
52wk Low:155.08
Shares:40.01M
Float Shares:38.77M
Volume Ratio:2.55
T/O Rate:0.05%
Dividend:0.40
Dividend Rate:0.14%
EPS(TTM):5.39
EPS(LYR):3.85
ROE:16.27%
ROA:6.25%
PB:7.68
PE(LYR):72.67

Loading ...

Trump Administration in Advanced Talks for Stake in Venezuelan Oil Fields

Dow Jones
·
Aug 28

HUTCHMED Wins China NMPA Nod for ATLED in Advanced Liver Cancer

TIPRANKS
·
Aug 28

Advanced Energy EVP, General Counsel Vonne Elizabeth Karpinski Sells 907 Shares Worth $263,575.35

Reuters
·
Aug 28

Solstice Advanced Materials Terminates Element Solutions Merger

MT Newswires Live
·
Aug 28

Solstice Advanced Materials announces $500M share repurchase program

TIPRANKS
·
Aug 28

Press Release: Element Solutions Announces Mutual Termination of Merger Agreement with Solstice Advanced Materials

Dow Jones
·
Aug 28

How Investors Are Reacting To Amkor Technology (AMKR) AI-Fueled Earnings And Advanced Packaging Expansion

Simply Wall St.
·
Aug 27

ImmuneOnco Starts Phase II Trial of Dual-Immunotherapy Combo for Advanced Liver Cancer

TIPRANKS
·
Aug 27

Fosun Pharma Unit Secures Exclusive Rights to Advanced Bispecific Antibody Drug

TIPRANKS
·
Aug 27

The Bull Case For Uniti Group (UNIT) Could Change Following Elevation To Cato Advanced Partner Tier

Simply Wall St.
·
Aug 27

Morgan Stanley Keeps Their Buy Rating on CNGR Advanced Material Co., Ltd. Class H (2579)

TIPRANKS
·
Aug 27

Lam Research Marks Construction of New Oregon Lab for Advanced AI Chip Development

MT Newswires Live
·
Aug 27

Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

GlobeNewswire
·
Aug 26

Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plc

GlobeNewswire
·
Aug 26

Advanced Info Service Forms New Subsidiary

MT Newswires Live
·
Aug 26

Morgan Advanced Materials Signals Steady Progress Amid Headwinds

TIPRANKS
·
Aug 26

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

GlobeNewswire
·
Aug 25

RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer

GlobeNewswire
·
Aug 25

CNGR Advanced Material Directors Approve Budget Increase for Daily Related-Party Transactions with Two Entities

MT Newswires Live
·
Aug 25

CNGR Advanced Material Revises Interim Dividend and Sets Cross-Border Tax Terms

TIPRANKS
·
Aug 25